课题基金 / 基金详情

HDAC8调控PPARγ在体外循环相关急性肾损伤后适应不良性修复中的作用及机制研究

批准号:
82102288
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张贇和
依托单位:
学科分类:
器官功能衰竭与支持
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张贇和

项目摘要

结项摘要

相似基金

相关文献

中文摘要
体外循环患者常因缺血再灌注诱发急性肾损伤,即使进入恢复期后也常伴发肾损伤后适应不良性修复,进而导致肾慢性纤维化。申请人前期研究证实,HDAC8作为一种特殊的组蛋白去乙酰化酶能在慢性肾纤维化过程中,通过多条成纤维信号通路,影响纤维化进程。PPARγ是一种参与肾脏稳态维持的转录因子,其功能受多种表观遗传学,包括乙酰化在内的影响。有研究表明PPARγ乙酰化可以在慢性肾功能不全中起到保护作用,但就其能否影响急性肾损伤后适应不良修复仍为未知。本研究拟建立缺血再灌注致急性肾损伤后肾适应不良性修复模型,通过干预HDAC8及PPAR-γ的表达水平,观察HDAC8对PPARγ的调控作用及对肾上皮间充质转化及间质纤维化的影响,进而评价HDAC8作为潜在靶点对治疗体外循环患者急性肾损伤后适应不良修复的作用。
英文摘要
Acute kidney injury is the most common postoperative comorbidity in patients receiving cardiopulmonary bypass surgery. Patients often suffer maladaptive repair after the incomplete recovery of postoperative AKI and turn into chronic renal disease finally. Our previous research revealed that HDAC8, as a special histone deacetylase, can affect kidney fibrosis process by regulating several fibroblasts signaling pathway. PPARγ is a nuclear transcription factor involves in a wide range of physiological and pathological processes. Its function is affected by a variety of epigenetics, including acetylation. Studies showed that the acetylation of PPARγ can play a protective role in chronic renal fibrosis. However, whether it can affect the maladaptive repair after AKI is still unknown. This study intends to establish a renal maladaptive repair model after AKI. By adjusting the expression of HDAC8 and PPARγ, we try to explain the effect of HDAC8 on PPARγ and its influence on renal epithelial-mesenchymal transition and interstitial fibrosis. This study also evaluates the role of HDAC8 as a potential target for treating the maladaptive repair after AKI caused by cardiopulmonary bypass surgery.
体外循环手术常因低流量及非搏动性血流致使术中肾脏灌注降低,导致入球小动脉持续收缩,肾小球滤过率的下降,进而损伤肾小管,引发急性肾损伤。其中相当部分病例会出现损伤后适应不良性修复进而进展为慢性肾功能不全造成患者生活质量下降及巨大医疗财政负担。本课题通过构建小鼠急性肾损伤后进展为慢性肾损伤模型,聚焦于急性肾损伤后适应不良性修复过程,探索以组蛋白乙酰化蛋白家族成员之一HDAC8作为干预靶点对急性肾损伤后适应不良性修复的影响,同时验证其可能的调控机制。本研究成功建立急性肾脏病模型,同时通过HDAC8抑制剂处理,我们观察到抑制HDAC8能显著降低急性肾损伤后肾间质纤维化发生,减轻病理破坏。在急性肾损伤事件发生后,抑制HDAC8能上调PPARγ,通过Smad3、Stat3以及WNT/β-catenin多条通路,抑制纤维化进程同时减少肾小管上皮细胞EMT转化。同时我们也在细胞模型中进行相关机制通路的验证。本课题明确提出一项影响急性肾损伤后的后适应不良性修复进程的关键信号通路并验证其干预靶点,为急性肾损伤后病理生理过程的认识及相关干预药物的开发提供一定思路。
国内基金
海外基金